Search - tctmd.com

Displaying 1 - 20 of 82

Sort: Relevancy | Date

News Industry News

Concept Medical Announces Enrollment of First Patient in “Magical-ISR” IDE Study in the US

April 19, 2024

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

News Industry News

Efemoral Medical Announces Successful First-In-Human Use of The Efemoral™ Vascular Scaffold System

December 14, 2020

News Industry News

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

February 26, 2018

News Industry News

REVA Receives CE Mark for Fantom

April 04, 2017

News Industry News

REVA to Expand FANTOM II Trial to More Complex Cases

March 24, 2017

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

News Industry News

Tallahassee Memorial HealthCare Becomes First Hospital in Florida to Offer and Deploy First-of-Its-Kind Naturally Dissolving Heart Stent

July 14, 2016

News Industry News

CorMatrix® CanGaroo® ECM® Envelope Receives CE Mark Approval

June 28, 2016

News Industry News

Medinol Announces Outstanding Results in a Randomized Trial of a New Drug Eluting Stent

May 17, 2016

News Industry News

NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient

March 21, 2016

News Industry News

REVA Achieves Target Patient Enrollment in FANTOM II Trial

February 23, 2016

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

News Industry News

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

January 06, 2016

News Industry News

Carnegie Mellon Researchers Hack Off-the-Shelf 3-D Printer Towards Rebuilding the Heart

October 26, 2015

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

October 12, 2015

News Industry News

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

October 12, 2015

News Industry News

REVA Completes Clinical Enrollment Milestone

October 01, 2015

Advertisement

Concept Medical Announces Enrollment of First Patient in “Magical-ISR” IDE Study in the US

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

Efemoral Medical Announces Successful First-In-Human Use of The Efemoral™ Vascular Scaffold System

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

REVA Receives CE Mark for Fantom

REVA to Expand FANTOM II Trial to More Complex Cases

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

Tallahassee Memorial HealthCare Becomes First Hospital in Florida to Offer and Deploy First-of-Its-Kind Naturally Dissolving Heart Stent

CorMatrix® CanGaroo® ECM® Envelope Receives CE Mark Approval

Medinol Announces Outstanding Results in a Randomized Trial of a New Drug Eluting Stent

NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient

REVA Achieves Target Patient Enrollment in FANTOM II Trial

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

Carnegie Mellon Researchers Hack Off-the-Shelf 3-D Printer Towards Rebuilding the Heart

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

REVA Completes Clinical Enrollment Milestone

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content